Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The Endocrine Society's 2024 guidelines on obesity pharmacotherapy recommend GLP-1 receptor agonists as first-line medication options for patients meeting these thresholds [3]
Focus on Net Cost: For high-value claims, transparency ensures that every discount, manufacturer copay card, and negotiated price is applied directly to the employers benefit, preventing spread pricing on GLP-1 claims
Your body will use what it needs and naturally flush out the rest through urine
For details about eligibility and treatment options, please contact our office
At the weight management dose of 2.4 mg, semaglutide causes roughly 2.5 to 4 times more vomiting than tirzepatide at its highest dose
US$ 20.60
US$ 24.89
US$ 27.52
US$ 29.19
US$ 25.58
